GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Senores Pharmaceuticals Ltd
Senores Pharmaceuticals Schedules Q2 & H1 FY27 Earnings Conference Call
RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 22 Oct 2026, 06:10 PM IST  ·  BSE ID: 1f391977-e9a0-400d-9c8e-0fc9af974b45
View Original BSE Filing (PDF)
💡
In Simple Terms
Senores Pharmaceuticals will hold a public call on October 29, 2026, to discuss its financial results for July-September 2026.
🤖 AI Summary
  • Senores Pharmaceuticals Ltd will hold its Q2 and H1 FY27 earnings conference call on October 29, 2026, at 05:00 P.M. (IST).
  • The call follows the announcement of the unaudited consolidated and standalone financial results for the period ended September 30, 2026.
  • Key management, including Mr. Swapnil Shah, Mr. Sanjay Majmudar, and Mr. Deval Shah, will represent Senores Pharmaceuticals.
  • DAM Capital Advisors Ltd is organizing the post-results conference call, with Nitin Agarwal as the analyst leader.
  • Audio recording and transcript of the call will be published on the company's website subsequently.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders. Shareholders interested in financial performance discussions can attend the earnings call.
👤
Who Is Affected
All current and prospective shareholders of Senores Pharmaceuticals Ltd may be affected by the financial results and discussions presented during the call.
🔍
Management Signal
The decision to hold an earnings call indicates management's intent to communicate financial performance and operational updates directly to the investor community.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Announcement of Un-audited Consolidated and Standalone Financial Results for Q2 & H1 FY27.
Proceedings of the earnings conference call on October 29, 2026.
Publication of the audio recording and transcript of the earnings call on the company website.
LOW RISK This is a standard procedural announcement for an earnings call and does not introduce new risks.
💡 Investor Takeaway
Senores Pharmaceuticals Ltd has scheduled an earnings conference call for Q2 and H1 FY27 on October 29, 2026, at 05:00 P.M. (IST) to discuss the unaudited consolidated and standalone financial results for the period ended September 30, 2026.
📅 Company Track Record
Senores Pharmaceuticals Ltd reported Q1 FY27 consolidated Net Profit after tax up 43.77% YoY to Rs. 30.45 Crore in July 2026. For FY26, the company's Total Income increased by 65% to Rs. 664 Crs, with PAT rising by 108%, as noted in May 2026 filings. This indicates a trend of significant growth in recent financial periods.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
When is Senores Pharmaceuticals Ltd's Q2 and H1 FY27 earnings conference call?
Senores Pharmaceuticals Ltd will hold its earnings conference call for Q2 and H1 FY27 on Thursday, October 29, 2026, at 05:00 P.M. (IST).
What financial periods will be discussed in the Senores Pharmaceuticals earnings call?
The earnings conference call will discuss the Un-audited Consolidated and Standalone Financial Results for the quarter and half year ended on September 30, 2026.
Who are the management speakers for the Senores Pharmaceuticals Q2 & H1 FY27 earnings call?
The management speakers for the call include Mr. Swapnil Shah (Promoter and Managing Director), Mr. Sanjay Majmudar (Chairman), and Mr. Deval Shah (Whole Time Director and Chief Financial Officer).
Where will the audio recording and transcript of the earnings call be available?
The audio recording and transcript of the earnings call will be subsequently published on the website of Senores Pharmaceuticals Limited.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.